Virtu Financial’s Ernexa Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
Other funds holding ERNA
Virtu Financial's ERNA Position: Q4 2022 in Review
Virtu Financial sold out of Ernexa Therapeutics (ERNA) in Q4 2022, closing a stake of 8 shares — an estimated $16K sold.
Virtu Financial first reported a position in ERNA in Q3 2020 and held it in 3 quarters. The position peaked at $68K in Q1 2021. 11 funds tracked by Wall St. Rank hold ERNA as of Q4 2022.
- Virtu Financial reported no remaining Ernexa Therapeutics position as of Q4 2022 after selling out during the quarter.
- Virtu Financial sold 8 Ernexa Therapeutics shares in Q4 2022, an estimated $16K.
- Virtu Financial first reported a position in Ernexa Therapeutics in Q3 2020 and held it in 3 quarters.
- Virtu Financial's Ernexa Therapeutics position peaked at $68K in Q1 2021.
- 11 funds tracked by Wall St. Rank held Ernexa Therapeutics as of Q4 2022.
Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.